A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 1, Issue 6, 2006, Pages 532-536

  Aerts, J G J V ^a,b   Surmont, V ^a   Van Klaveren, R J ^a   Tan, K Y ^b   Senan, S ^c   Van Wijhe, G ^a   Vernhout, R ^a   Verhoeven, G T ^b   Hoogsteden, H C ^a   Van Meerbeeck, J P ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Sint Franciscus Gasthuis ^*  (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Carboplatin; Gemcitabine; Induction; Locally advanced NSCLC

Indexed keywords

CARBOPLATIN; GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DYSPNEA; FEBRILE NEUTROPENIA; FEMALE; HOSPITALIZATION; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; CANCER INVASION; CANCER STAGING; CONFIDENCE INTERVAL; DENMARK; DOSE RESPONSE; DRUG ADMINISTRATION; LUNG TUMOR; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROBABILITY; PROGNOSIS; REMISSION; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; DENMARK; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34247866516     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200607000-00006     Document Type: Article

References (12)

1. Vokes JEH, Crawford J, Leopold MC, et al. Randomized phase II study of cisplatin with gemcitabine of paclitaxel or vinorelbine as induction chemotherapy followed by concomittqant chemoradiotherapy for stage IIIB non-small cell lung cvancer: cancer and leukemia group B study 9431. J Clin Oncol 2002;20:4191-4198.
2. Rowell NP. Concurrent chemoradiotherapy in non-small cell lung cancer. The cochrane database of systematic reviews, 2004;18:C0002140.
3. Fournel P, Thomas P, Souquet PJ, et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 2006;23: 5910-5917.
4. van Zandwijk N, Kramer GWP, Schramel S, et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer lung cancer cooperative group (EORTC 08955). J Clin Oncol 2000;18:2658-2664.
5. le Chavalier T, Natale R, Danson S, et al. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small cell lung caqncer: a meta-analysis of survival outcomes. Lung Cancer 2006;47:69-80.
6. Zatloukal M, Kolek J, Skrickova M, et al. Gemcitabine plus cisplating vs gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial. Lung Cancer 2003;41:321-331.
7. Hotta K, Ueoka H, Kiura K, et al. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small cell lung cancer. J Clin Oncol 2004;22:3852-3859.
8. Mazzanti P, Rocchi MB, Mattioli R, et al. Gemcitabine-cisplatin vs. gemcitabine-carboplatin in advanced non-small cell lung cancer: a multicenter phase II randomized trial. Lung Cancer 2001;37:81-89.
9. Argiris ML, LaCombe M, Marymont MS, et al. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. Lung Cancer 2004;45:243-253.
10. Hirsh DS, Duclos MP, Del Vecchio L, et al. Phase II trial with carboplatin/gemcitabine induction chemotherapy followed by radiotherapy concomitantly with paclitaxel/gemcitabine in stage III non small cell lung cancer. Lung Cancer 2006;2005:S169.
11. Kortsik C, Elmer A. Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study (Abstract). Lung Cancer 2003;40:85-90.
12. Vokes EE, Kelley MJ, Watson D, et al. Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): initial analysis of a randomized phase III trial (Abstract). Proc ASCO 2004;7005.